MD Anderson Cancer Center and UICC collaborate to improve women’s cancer care

The University of Texas MD Anderson Cancer Center recently announced an agreement to become a Women’s Cancer Partner with the Union for International Cancer Control (UICC), marking a significant collaboration to improve breast and cervical cancer care worldwide.

In this capacity, MD Anderson will actively participate in UICC’s initiatives aimed at addressing women’s cancers, with a focus on strategic development, knowledge-sharing and global advocacy.

UICC is the largest global organization dedicated to reducing the global cancer burden and ensuring that cancer control is integrated into world health and development agendas. Founded in 1933 and headquartered in Geneva, Switzerland, UICC unites over 1,100 member organizations across 170 countries working to advance cancer prevention, treatment and care. Through partnerships, advocacy and capacity-building programs, UICC aims to reduce the inequities in cancer care and improve outcomes for millions of people affected by cancer worldwide.

MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the world and one of the original three NCI-designated comprehensive cancer centers in the country. The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

Breast and cervical cancers stand out as significant global health challenges. Breast cancer is the most common cancer worldwide and the leading cause of cancer-related deaths in women, while cervical cancer remains the fourth most prevalent. Both diseases disproportionately affect low- and middle-income countries, highlighting global health inequities.

This agreement strengthens the ongoing collaboration between MD Anderson and UICC, following their joint participation in the Asia-Pacific Regional Dialogue on women’s cancers and the World Cancer Leaders’ Summit. Under this new agreement, MD Anderson will contribute to the impact and reach of the UICC’s breast and cervical cancer programs.

On this Occasion MD Anderson Cancer Center posted on LinkedIn:

“Because breast and cervical cancers are significant global health challenges, MD Anderson and the Union for International Cancer Control (UICC) are collaborating to address these cancers worldwide.

‘I look forward to working with my esteemed colleagues on the board to advance UICC’s mission, particularly in addressing the disparities in cancer care and outcomes across different regions. Together, we can significantly reduce the global cancer burden and ensure that quality cancer care is accessible to all, regardless of where they live,’ says our Dr. Kathleen Schmeler.”

MD Anderson Cancer Center’s President Peter Pisters also shared on this occasion:

“We are proud to work with UICC to strengthen global efforts in the prevention, diagnosis and treatment of women’s cancers. This collaboration offers a valuable opportunity to share collective expertise, work alongside global leaders and make a significant impact addressing breast and cervical cancers, particularly in resource-limited regions that are disproportionately affected by these diseases.”

For more such information, visit oncodaily.com.